GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
12.19
-0.25 (-2.01%)
At close: Jun 30, 2025, 4:00 PM
11.00
-1.19 (-9.76%)
After-hours: Jun 30, 2025, 6:12 PM EDT
GH Research Market Cap
GH Research has a market cap or net worth of $753.64 million as of June 30, 2025. Its market cap has increased by 20.71% in one year.
Market Cap
753.64M
Enterprise Value
438.96M
1-Year Change
20.71%
Ranking
Category
Stock Price
$12.19
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has decreased from $808.33M to $753.64M, a decrease of -6.77%. That is a compound annual growth rate of -1.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 771.63M | 111.87% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 698.44B |
| Johnson & Johnson | 365.46B |
| AbbVie | 326.82B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 281.34B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 235.63B |
| AstraZeneca | 217.42B |